Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Qiagen NV QGEN

Technology Scientific & Technical Instruments
Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic... see more

Recent & Breaking News (NYSE:QGEN)

QIAGEN Launches Portable Digital SARS-CoV-2 Antigen Test That Can Accurately Analyze Over 30 Samples Per Hour

Business Wire November 11, 2020

QIAGEN N.V. to hold investor call on Wednesday, October 28, after releasing results for Q3 2020 and first nine months of 2020

Business Wire October 27, 2020

QIAGEN Reports Strong Results for Third Quarter and First Nine Months of 2020 and Increases Outlook for Full-Year 2020

Business Wire October 27, 2020

QIAGEN reports strong preliminary results for third quarter of 2020

Business Wire October 13, 2020

QIAGEN to Complement COVID-19 Testing Portfolio With Novel Kit That Simplifies and Accelerates PCR Analysis for Research Applications

Business Wire October 5, 2020

QIAGEN fully acquires NeuMoDx Molecular, Inc., rounding out portfolio of PCR-based diagnostic automation systems

Business Wire September 17, 2020

QIAGEN to Launch Rapid Portable Test That Can Analyze Over 30 Samples Per Hour for SARS-CoV-2 Antigen

Business Wire September 8, 2020

QIAGEN to Launch Easy-to-Use Digital Test in the U.S. for Rapid Detection of SARS-CoV-2 Antibodies Following FDA Emergency Use Authorization

Business Wire August 24, 2020

QIAGEN announces new Chairman of Supervisory Board

Business Wire August 21, 2020

QIAGEN Expands Integrated Coronavirus NGS and Software Solutions to Accelerate COVID-19 Research

Business Wire August 18, 2020

QIAGEN to Continue Successful Growth Strategy Focused on Execution and Greater Value Creation After Voluntary Public Takeover Offer Falls Short

Business Wire August 13, 2020

Thermo Fisher Scientific Announces Results of Offer to Acquire QIAGEN, Lapse of Offer and Termination of Acquisition Agreement

PR Newswire August 13, 2020

Thermo Fisher Scientific Provides Process Overview for the Announcement of Final Offer Results

PR Newswire August 11, 2020

HTG Molecular Diagnostics Announces New Commercialization and Distribution Agreement for Companion Diagnostics with QIAGEN

GlobeNewswire August 10, 2020

QIAGEN Reports Full Results for Second Quarter and First Half Of 2020

Business Wire August 4, 2020

QIAGEN announces publication of Supplemental Reasoned Position Statement for proposed acquisition by Thermo Fisher

Business Wire July 22, 2020

Thermo Fisher Scientific and QIAGEN N.V. Agree on Amended Terms to Acquisition Agreement

PR Newswire July 16, 2020

QIAGEN Shareholders Approve All Agenda Items Related to Acquisition by Thermo Fisher Scientific at Annual General Meeting

Business Wire June 30, 2020

QIAGEN Announces Plans to Release Preliminary Q2 2020 Results

Business Wire June 22, 2020

Rigrodsky & Long, P.A. Files Class Action Suit Against QIAGEN N.V.

GlobeNewswire June 18, 2020